Core Insights - Milestone Scientific Inc. has appointed Eric C. Hines as the new Chief Executive Officer, effective immediately, to drive the company's next phase of commercial execution [1][3] Company Overview - Milestone Scientific Inc. is a technology-focused medical research and development company that specializes in innovative injection technologies for medical and dental applications [4] - The company utilizes its proprietary DPS Dynamic Pressure Sensing Technology platform to enhance the precision and efficiency of injections, thereby improving patient comfort and safety [4] Leadership Experience - Eric C. Hines brings over 25 years of leadership experience in scaling sales-driven enterprise software companies, with a notable track record in the healthcare sector [2] - Prior to joining Milestone, Hines served as President of North America at Ex Libris, where he successfully increased annual revenue from approximately $50 million to over $100 million [2] Strategic Goals - The company aims to accelerate the adoption of its CompuFlo technology, which has made significant progress in reimbursement, including Medicare Part B payment rates under CPT code 0777T [3] - Hines expressed a commitment to expanding Milestone's presence in both medical and dental markets, as well as pursuing new clinical indications and global opportunities [3] Market Opportunities - There are compelling opportunities identified in the dental segment, particularly with Milestone's STA system, which is noted for its differentiation in the market [3] - The company is focused on leveraging recent reimbursement achievements to support expanded commercial adoption of its technologies [3]

Core Insights - Milestone Scientific Inc. has announced the integration of its CompuFlo® Epidural System at InfiniSurg, LLC, a New Jersey-based ambulatory surgery center, enhancing its clinical practice with advanced technology [1][3][4] Company Overview - Milestone Scientific Inc. (NYSE: MLSS) specializes in developing computerized drug delivery instruments aimed at providing painless and precise injections, focusing on improving patient comfort and safety [5] - The company’s proprietary Dynamic Pressure Sensing Technology® is designed to enhance the precision of injections and reduce complications associated with traditional methods [5] Technology and Innovation - The CompuFlo® Epidural System utilizes objective pressure sensing technology to provide real-time feedback, which may enhance procedural confidence and reduce complications during epidural placements [3][4] - The system aims to establish a new standard of care for epidural procedures by improving procedural efficiency and patient safety through visual and audible feedback mechanisms [4] Leadership and Expertise - Dr. Roman Kosiborod, a highly experienced anesthesiologist and pain management physician, will utilize the CompuFlo® Epidural System at InfiniSurg, bringing over two decades of expertise in interventional pain management [2][3] - InfiniSurg is recognized for its patient-centric approach and commitment to innovation in outpatient surgical care, aligning with Milestone's mission to leverage advanced technologies for better patient outcomes [3]